$BIO

AI Analysis

Generated on May 11, 2026

AI Score
56/ 100
Hold$BIO

Bio-Rad Laboratories

$BIONYSEHealthcareLarge-Cap

Bio-Rad manufactures and sells clinical diagnostics products and life science research instruments globally.

Market Cap
$8.0B
Revenue (TTM)
$2.5B
-5.0%
Net Income (TTM)
$0.15B
-20.0%
EPS (TTM)
$5.00
P/E Ratio
62.0
Dividend Yield
0.0%
52-Week Range
$260-$420
Beta
0.62
Dimension Scores
Fundamental
54
Technical
52
Sentiment
58
Risk / Reward
60
Momentum
48
FundTechSentRiskMome
Financial Health
Profitability
59moderate
Growth
51weak
Liquidity
68strong
Solvency
56moderate
Efficiency
52moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $BIO

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.